THEME:Advanced treatments and technologies in cancer therapies
Global Staunch takes immense delight & feels honored in inviting the participants across the globe to attend the "Cancer Therapy and Survivability 2019 conference" which is held during November 14th - 15th, 2019, Kuala Lumpur, Malaysia. In objective to inspire young minds and their research abilities by providing an opportunity to meet professionals in the field of Cancer Research. To spread cancer awareness, and educate people about advances in the treatment of cancer and the development of new cancer treatment to reduce the risk and to develop a painless treatment. It is the second major cause for death globally and it is hard to cure disease.
The main theme of our conference is “Advanced treatments and technologies in cancer therapies”. With the intention to get answers concerning any type of cancer. Some of the treatments are mention below i.e. chemotherapy and radiotherapy, immunotherapy, Surgery, targeted therapy, hormone therapy, stem cell therapy, precision medicine.
In recent years, novel concepts have been emerging to improve the traditional therapeutic options in cancers with poor survival outcomes. New therapeutic strategies involving areas like energy metabolism and extracellular vesicles along with advances in immunotherapy and nanotechnology. it also provides a stimulating scientific environment and platform for the participants to share ideas and knowledge, collaborate on related problems and network with other professionals.
Advancement in cancer treatment i.e immunotherapy advances Checkpoint inhibitors proven valuable as initial therapy for advanced lung cancer, Combination immunotherapy boosts renal cell cancer survival, established a new standard, Investigational PD-1 inhibitor shows promise for a skin cancer with few treatment options, Pembrolizumab provides greatest benefits in head and neck cancers with high PD-L1 expression, Chimeric antigen receptors T-cell (CAR-T) therapy trails show long-term benefits
This conference also focuses on survival after fighting with complicated diseaseS. Survival statistics for treatment of cancer shown advancement i.e. breast cancer, colon cancer, esophageal cancer, kidney cancer, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, Combination immunotherapy can reduce brain metastases in people with melanoma rectal cancer.
TO CHOOSE FROM